MAP1A and cancer: Compared with normal bladder tissues, single-gene MAP1A decreased in various cancers (BLCA, BRCA, COAD, GBM, KICH, PRAD, READ, THCA, and UCEC, P < 0.001), while it increased in CHOL and LIHC (P < 0.001).